Profiel
Curtis Rambaran is currently Chief Medical Officer at Silence Therapeutics Plc since 2023.
Dr. Rambaran was Head-European Translational Medicine at Daiichi Sankyo UK Ltd. from 2016 to 2023.
Dr. Rambaran earned a doctorate from The University of the West Indies.
Actieve functies van Curtis Rambaran
| Bedrijven | Functie | Begin |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Eerdere bekende functies van Curtis Rambaran
| Bedrijven | Functie | Einde |
|---|---|---|
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 01-12-2023 |
Opleiding van Curtis Rambaran
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The University of the West Indies
The University of the West Indies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo UK Ltd.
Daiichi Sankyo UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
















